Spur Therapeutics Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 256

Employees

  • Latest Deal Type
  • Buyout/​LBO

  • Latest Deal Amount
  • $50M

Spur Therapeutics General Information

Description

Developer of genetic therapies designed to address complex medical conditions. The company offers in vivo gene therapy research, therapeutic protein engineering, viral vector development and clinical-stage genetic medicine programs for debilitating chronic diseases, enabling patients and healthcare providers to access potential treatments that address underlying disease mechanisms and may reduce the need for ongoing therapy.

Contact Information

Formerly Known As
Newincco 1354, Freeline, Freeline Therapeutics
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Sycamore House
  • Gunnels Wood Road
  • Stevenage SG1 2BP
  • England, United Kingdom
+44 01438
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Sycamore House
  • Gunnels Wood Road
  • Stevenage SG1 2BP
  • England, United Kingdom
+44 01438

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Spur Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Buyout/LBO 17-Jun-2024 $50M Completed Clinical Trials - Phase 2
7. PIPE 01-Mar-2022 Completed Clinical Trials - Phase 2
6. IPO 07-Aug-2020 Completed Pre-Clinical Trials
5. Later Stage VC (Series C) 30-Jun-2020 Completed Pre-Clinical Trials
4. Early Stage VC (Series B) 19-Jun-2018 Completed Product Development
3. Early Stage VC (Series A) 11-Dec-2015 Completed Product Development
2. Angel (individual) 22-May-2015 $17M $17M Completed Startup
1. University Spin-Out 01-Jan-2015 Completed Startup
To view Spur Therapeutics’s complete valuation and funding history, request access »

Spur Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B
Series C
Series A 34,740,000 $0.000013 $1.25 $1.25 1x $1.25 28.3%
To view Spur Therapeutics’s complete cap table history, request access »

Spur Therapeutics Patents

Spur Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202119033-D0 Assay Inactive 24-Dec-2021
GB-202119034-D0 Polypeptide Inactive 24-Dec-2021
WO-2023079301-A1 Assays using mutant complement factor i variants with decreased activity Inactive 04-Nov-2021
WO-2023079297-A1 Mutant complement factor i variants with increased activity Inactive 04-Nov-2021
GB-202109231-D0 Promoter Inactive 25-Jun-2021 C07K14/755
To view Spur Therapeutics’s complete patent history, request access »

Spur Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Spur Therapeutics Acquisitions (1)

Spur Therapeutics’s most recent deal was a Merger/Acquisition with SwanBio Therapeutics. The deal was made on 25-Jun-2024.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
SwanBio Therapeutics 25-Jun-2024 Merger/Acquisition Drug Discovery
To view Spur Therapeutics’s complete acquisitions history, request access »

Spur Therapeutics Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
SwanBio Therapeutics Bala Cynwyd, PA 2017

Spur Therapeutics FAQs

  • When was Spur Therapeutics founded?

    Spur Therapeutics was founded in 2015.

  • Where is Spur Therapeutics headquartered?

    Spur Therapeutics is headquartered in Stevenage, United Kingdom.

  • What is the size of Spur Therapeutics?

    Spur Therapeutics has 256 total employees.

  • What industry is Spur Therapeutics in?

    Spur Therapeutics’s primary industry is Drug Discovery.

  • Is Spur Therapeutics a private or public company?

    Spur Therapeutics is a Private company.

  • What is the current valuation of Spur Therapeutics?

    The current valuation of Spur Therapeutics is .

  • What is Spur Therapeutics’s current revenue?

    The current revenue for Spur Therapeutics is .

  • How much funding has Spur Therapeutics raised over time?

    Spur Therapeutics has raised $484M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process